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Abstract: Differential vascular remodeling is one of the major mechanisms of heterogeneity 
in atherosclerosis. The structural and functional heterogeneity between arteries and veins 
determines the degree of vascular remodeling. Matrix metalloproteases (MMPs) and their 
tissue inhibitors (TIMPs) play key roles in vascular structural and functional remodeling. We 
hypothesized that the level of blood flow in different arteries and veins caused structural and 
functional heterogeneity that ultimately determined potential vascular remodeling. To test 
this hypothesis, in vivo blood flow and blood pressure in the aorta, carotid, femoral artery, 
and femoral vein was measured in male Sprague-Dawley rats (weight 380–400 gm). Arterial 
and venous pressures were measured by PE-50 catheter cannulation. Blood flow was mea-
sured by a transonic ultrasound system. The aortic arch, femoral and carotid arteries, and 
abdominal vena cava were isolated to determine the expression of MMP-2, -9, -12, and -13 and 
TIMP-1, -3, and -4 by Western blot and in gelatin gel zymography. Masson trichrome and van 
Gieson stains were used to stain the histologic tissue sections. The results revealed that blood 
flow was higher in the aorta and carotid artery than the femoral artery and vein. MMP-9 and 
MMP-13 were higher in the carotid artery in comparison with the other blood vessels, while 
TIMP-3 showed higher expression in the aorta than the arteries. Further, the MMP-9 activity 
was significantly higher in the carotid artery than in the aorta and femoral artery. There was a 
higher degree of basement membrane collagen in the femoral artery and therefore a low elastin: 
collagen ratio, while in the carotid artery a higher level of elastin and, therefore, a high elastin: 
collagen ratio was found. The results suggested that medial thickness and elastin:collagen 
ratios had a threshold in blood flow in the range 0.6–2.5 mL/min, which increased robustly if 
blood flow increased to 2.7 mL/min. This pattern was inverted by the total MMP:TIMP ratio. 
We conclude that vascular remodeling is a function of rate of blood flow, which would in turn 
be determined by the amounts of MMPs and their inhibitors present. The study combined the 
endothelial and dynamic (blood flow/pressure) components that affect medial thickness and 
elastin: collagen ratios.
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Introduction
Collagen and elastin are two vital components of the blood vessel. Conduit arteries 
like the carotid and femoral artery and the aorta may undergo remodeling in response 
to structural modifications in these proteins.1 Elastin comprises 90% of elastic arterial 
fibers.2 Elastin enables many tissues in the body to resume their shape after stretching 
or contracting. Many soluble tropoelastin proteins, the subunit of larger elastin 
aggregate, cross link to form elastin which is a large insoluble protein. Collagen is 
the most common protein in mammals (25% to 35% of whole body protein content). Vascular Health and Risk Management 2010:6 216
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It is a main protein of connective tissue. The tropocollagen 
or “collagen molecule” is a subunit of larger collagen 
aggregates. As the distance of the blood vessel from the 
heart increases, the number of vascular smooth muscle cells 
increase. However, the ratio of elastin and collagen tend 
to decrease with increasing distance from the heart.3–6 In 
comparison with collagen, elastin has a slow turnover ratio.7 
Elastinolysis and collagenolysis play crucial roles in arterial 
remodeling and diseases.8
One of the crucial underlying mechanisms for vascular 
remodeling is the function of matrix metalloproteinases 
(MMPs) and tissue inhibitors of metalloproteinases (TIMPs).9–15 
MMPs are zinc-dependent proteins that work as proteases and 
allow the degradation and restructuring of the extracellular 
matrix collagens and elastin.16–24 Although MMP-2 (gelatinase-
A, 72 kDa) and MMP-9 (gelatinase-B, 92 kDa) are found in 
the extracellular matrix of all vascular smooth muscle cells, 
MMP-2 is constitutive and MMP-9 is inducible. They work 
on substrates like collagen Type 4, elastin, and several other 
extracellular matrix (ECM) molecules. MMP-2 is mainly 
localized in the thickened intima,1,25 and digests interstitial 
collagen Types 1, 2, and 3.16,26 Both MMP-2 and MMP-9 show 
structural similarity with fibronectin.27 MMP-2 is commonly 
found and synthesized by many cells, especially by fibroblasts, 
keratinocytes, chondrocytes, endothelial cells, monocytes, 
and osteoblasts. MMP-9 can be activated by MMP-2 and is 
expressed in keratinocytes, monocytes, and pulmonary alveo-
lar macrophages.27 MMP-9 and -13 (collagenase-3) cleaves 
interstitial collagens 1, 2, and 3 into its characteristic ¼ th and 
¾ th fragments, and can also digest other ECM molecules and 
soluble proteins.16 These two proteinases are mainly produced 
during tumorogenesis and in some physiologic processes 
associated with an accelerated change of the ECM.27 MMP-
12 (macrophage metalloproteinase) is mainly synthesized by 
macrophages and works on substances like elastin Type 4 col-
lagen, vitronectin, and fibronectin.27 Under normal conditions, 
the activities of the MMPs are regulated by transcriptional 
activation of pro-MMP precursor zymogens, by TIMPs,27 and 
by the interaction with specific ECM components. Factors that 
regulate vessel remodeling, such as chronic changes in hemo-
dynamics, vessel injury, inflammatory cytokines, and reactive 
oxygen species are also known to regulate MMP activities.28 
TIMP binds MMPs in a 1:1 stoichiometry, and plays a pivotal 
role in balancing the action of MMPs.28 Four TIMPs have been 
identified in vertebrates, and their expression is regulated dur-
ing development and tissue remodeling.29 The TIMP-MMP 
complex is stable and irreversibly blocks the access of the 
substrate to the catalytic portion of the MMP. TIMPs also 
function as growth factors in some cells.30 TIMP-1, a 23 kDa 
mannose-rich glycoprotein is very stable. Glycosylation is not 
essential for the activity of this protein. TIMP-1 is sensitive to 
the serine proteases like trypsin, chymotrypsin, and elastase. 
TIMP-1 inhibits MMP-13 and MMP-2.27 TIMP-3, a recently 
discovered 30 kDa protein, inhibits activities of MMP-3, 
-7, -2, and -9. The structural homology of TIMP-3 with 
TIMP-1 and TIMP-2 is relatively weak. TIMP-4, a 23 kDa 
protein, works on MMP-9 and has a significant homology with 
TIMP-2. Like TIMP-2, it can bind to pro-MMP-2.9,31 It is now 
established that the MMPs are involved in hyperplasia of the 
intima and in weakening of atherosclerotic lesions leading 
to their rupture.18,32
Although intimal thickening is a systemic process 
involving most arteries,33 it was shown previously that 
different arteries exhibit different risk factors for developing 
atherosclerosis,26,34,35 but the causes behind this are still 
unknown. The present study was undertaken to investigate 
the relationship between blood flow and blood pressure with 
vascular morphology, and MMP and TIMP expression in 
different blood vessels.
Materials and methods
Animals
Adult male Sprague-Dawley rats (380–400 gm) were 
obtained from Harlan Industries Inc., Indianapolis, and 
housed in the animal care facility of the University of 
Louisville. All animals were fed a regular rodent diet. At the 
end of the experiments, rats were deeply anesthetized with 
pentobarbital (Ovation Pharmaceutical Inc., Chicago, IL) 
and sacrificed to harvest the aortic arch, carotid artery, 
femoral artery, femoral vein, and vena cava. All animal 
procedures were in accordance with the National Institutes 
of Health guidelines for animal research and were approved 
by the Institutional Animal Care and Use Committee of the 
University of Louisville.
In vivo blood pressure measurement
The rats were anesthetized by injection with 55 mg/kg 
pentobarbital. A small incision was made carefully in the 
throat area to isolate the carotid artery without damaging 
the nerve attached to the artery. The portion of the carotid 
artery proximal to the brain was tied with silk thread tightly, 
so that no blood could circulate towards the brain. Another 
silk thread was used to make a knot loosely at the part of 
the carotid artery proximal to the heart. A small incision 
was made between the two knots in the artery. Extreme care 
was taken to minimize damage to the endothelial layer of Vascular Health and Risk Management 2010:6 217
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the vessels of interest. A similar procedure was followed to 
isolate the femoral artery and the femoral vein. In the case of 
the femoral vein, the distal part of the vein was tied loosely 
and the proximal part was tied tightly with the silk thread. 
A catheter was inserted into the artery towards the heart. 
The other end of the catheter was attached to the pressure 
transducer. After catheterization, a heparin (100 µg/mL) 
(USB Corporation, Cleveland, OH) flush was done. The 
same procedures were used for the catheterization of the 
femoral artery. In the femoral vein, the catheterization was 
done towards the distal part of the body. The distal part 
of the catheter was then attached to the PE-50 catheter 
cannulation instrument (Digi-Med, US) and blood pressure 
was measured. The equipment was calibrated using a stan-
dard blood pressure meter in mmHg. The waveform of the 
blood pressure was recorded using DMSI-100 software.
In vivo blood flow measurement
A process similar to blood pressure measurement was used 
to measure the blood flow. A window was made in the 
throat area and in the joint of the proximal part of the hind 
leg and the torso to isolate the carotid artery and the femoral 
artery and vein, respectively, without damaging the nerves 
attached to the arteries. A transit time perivascular flow meter 
(Transonic System Inc, Ithaca, NY) was used to measure 
blood flow. A transonic flow probe 0.5PSB303 was used to 
measure blood flow from the carotid and femoral arteries 
and the femoral vein. The equipment was calibrated using a 
standard flow meter in mL/min. The waveform of the blood 
flow was recorded using DMSI-100 software.
Histologic tissue sectioning and staining
The carotid and femoral arteries and the aorta and vena 
cava were isolated from each animal. Extreme care was 
taken at the time of isolation to minimize tissue damage, 
especially any damage to the internal endothelial layer of 
the vascular wall. The tissues were cleaned in heparin and 
phosphate-buffered saline (PBS) to get rid of any unwanted 
blood and viscera. The tissues were then cut into 1–2 mm 
pieces. The tissue pieces were placed vertically in freezing 
media [Triangle Biomedical Sciences, Inc., Durham, NC] 
and frozen in liquid nitrogen. Immediately after this step, the 
frozen blocks with the molds were placed in a -70°C freezer. 
After one hour, the block was placed on a block holder which 
was then placed inside the microtome machine. A series of 
8 µm sections were cut and put on glass slides. The slides were 
then kept inside a -20°C freezer for storage. Before staining, 
the slides were kept for one hour at room temperature. For 
staining the tissue sections, a Masson trichrome staining kit, 
van Gieson’s staining kit and the hematoxylin and eosin frozen 
section staining kit (Richard Allen Scientific, Kalamazoo, 
MI) were used. Tissue sections were stained according to the 
protocols provided with the staining kits.
Western blotting technique
Samples of isolated carotid artery, femoral artery, and 
aortic arch and vena cava were taken from the anesthetized 
rats. RadioImmuno Precipitation Assay (RIPA, Thermo 
Scientific Inc., Rockford, IL) buffer was used for protein 
extraction. A bicinchoninic acid (BCA) assay was used for 
protein estimation; 35 µg total protein was loaded in each 
well of 8% sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) gels for detecting MMPs and 
in 12% SDS-PAGE gels for detecting TIMP expression. 
After overnight transfer at 100 milliamps, the membranes 
were blocked in 5% milk for one hour for TIMP detection 
or in 3% bovine serum albumin (BSA) for one hour in 
tris-buffered saline with Triton X100 (TBST) for MMP 
detection; 1:500 primary antibody concentrations were used 
for all protein detections. For MMP protein detection the 
antibodies were diluted with 3% BSA and for TIMP protein 
detection the antibodies were diluted with 5% milk in TBST. 
MMP-2 and MMP-9 antibodies were purchased from Abcam 
Antibodies, Cambridge, MA and MMP-13 and MMP-12 
antibodies were purchased from Santa Cruz Biotechnology, 
Santa Cruz, CA. TIMP-1 was purchased from R and D Sys-
tems, Minneapolis, MN. TIMP-3 was obtained from Affinity 
Bio Reagents, Golden, CO and TIMP-4 was purchased from 
Millipore, Billerica, CA. All the secondary antibodies were 
bought from Santa Cruz Biotechnology. Following overnight 
incubation at 4°C with shaking, the membrane was washed 
six times for 10 minutes each with TBST. HRP-conjugated 
mouse for MMP-2, TIMP-1 and rabbit secondary antibody 
for MMP-9, -12 and -13 and TIMP-4, 1:3000 dilutions in 
5% milk or in 3% BSA in TBST were used. Membranes 
were kept in secondary antibody for two hours at room 
temperature with shaking. After incubation in secondary 
antibody, the membranes were washed in TBST six times 
for 10 minutes each. An ECL plus Western blotting detection 
system (GE Health Care, Little Chalfont, Buckinghamshire) 
was used. After stripping with membrane-stripping buffer 
(Boston BioProducts, Worcester, MA) membranes were 
reprobed with β-actin (Sigma, St. Louis, MO) to verify 
protein loading and to normalize reported data. β-actin anti-
body was used in 1:5000 concentrations. A mouse secondary 
antibody at 1:6000 dilution was used.Vascular Health and Risk Management 2010:6 218
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Densitometric data analysis
Densitometric data were collected by scanning the Western 
blot bands depicting the proteins of interest and were 
normalized by dividing the data with β-actin densitometric 
data (U-Scanit Software). Graphs were plotted using the 
normalized data of interest.
In gel gelatin zymography
As described by Sen et al36 gelatin zymography was performed 
using 1.5% gelatin. Aorta, femoral and carotid artery, and vena 
cava tissues from rats were used for this purpose. RIPA buffer 
was used for protein extraction. The BCA assay was used for 
protein estimation; 56 µg of the protein was electrophoreti-
cally resolved for each sample in 8% SDS-PAGE containing 
1.5% gelatin as the MMP substrate. Gels were washed in 2.5% 
TBST for 30 minutes to remove SDS, rinsed in water, and 
incubated for at least 24 hours in activation buffer (50 mmol/L 
tris-HCl, 5 mmol/L CaCl2, and 0.02% NaN3, pH 7.5) at 37°C 
in a water bath with gentle shaking. Gels were then transferred 
to staining solution (acetic acid:methanol:water; 10:50:40, 
respectively) containing 0.5% Coomassie blue for one hour 
at room temperature. MMP activity in the gel was detected 
in a dark blue background with white bands.
Measurement of elastin and collagen 
intensity and blood vessel wall width
Blood vessels stained with Masson trichrome, van Gieson, 
or hematoxylin eosin stain were used. Pictures were taken 
by a camera attached to a Fluoview 1000 Olympus confocal 
microscope, and Qcapture software was used. All pictures 
were taken at 10 × magnification and were saved in JPEG 
format. In order to measure intensity of collagen and elastin 
staining of blood vessels, densitometric data were collected 
by using the same procedure as Western blot densitometry. 
Elastin:collagen ratio was calculated by dividing the 
densitometric data of elastin by the same data for collagen. 
Graphs were plotted using the data. Blood vessel widths 
were also measured by placing a scale on the photograph of 
hematoxylin eosin-stained vessels. Measurements were taken 
in centimeter scale, and were converted to a micron scale.
Passive stretch-tension relationship study
The aorta, carotid and femoral artery and the vena cava were 
isolated from the rat to measure the passive stretch–tension 
relationship. The blood vessels were placed in ice cold 
physiological salt solution (PSS, 118 mM NaCl, 4.7 mM 
KCl, 2.5 mM CaCl2, 1.2 mM KH2 PO4, 1.2 mM MgSO4, 
12.5 mM NaHCO3 and 11.1 mM glucose, pH 7.4). The 
solution was continuously aerated with 20% O2, 5% CO2, 
and 75% N2. Fat tissues and connective tissues were removed 
and the blood vessels were cut into 4 mm pieces for further 
study. The blood vessel rings were mounted with two tung-
sten wires of the same diameter which were attached to the 
myobath and were placed in a 25 mL organ bath filled with 
PSS at 37°C. The whole system was constantly aerated with 
O2:CO2, 95%:5%, respectively. Rings were stretched gradu-
ally to obtain the optimal resting tensions, which were 2 g 
for the aorta, 0.2 g for the femoral artery, and 0.1 g for the 
vena cava, and were calibrated for a minimum of an hour. 
After calibration, the passive-stretch tension relationship was 
obtained by increasing the stretch 1mm at each time. The 
resulting increase in tension (gm) was recorded graphically 
by using the mp100 software.
Statistical analysis
Each experiment was carried out using 3–6 specimens in each 
group. ANOVA was used to determine significance between 
groups; P  0.05 was considered significant. Values are 
means ± standard error of measurement (SE).
Results
Blood pressure and blood flow
Mean arterial pressure (MAP) in the carotid artery was 
139 ± 9 mmHg and average systolic and diastolic pressures 
were 157 ± 6 mmHg and 119 ± 4 mmHg, respectively. 
Average MAP in the femoral artery was 121 ± 6 mmHg. 
Average systolic and diastolic pressures were 137 ± 7 mmHg 
and 99 ± 5 mmHg, respectively. Average femoral vein mean 
blood pressure was 43 ± 3 mmHg, and average systolic 
and diastolic blood pressures were 53 ± 4 mmHg and 
36 ± 6 mmHg, respectively. Average heart rate was measured 
to be 300 ± 20 per minute in all rats. Although there was 
a tendency towards an increase in carotid blood pressure 
and a decrease in femoral artery blood pressure, it was not 
statistically significant (Figure 1).
Average carotid artery blood flow was 2.5 ± 0.3 mL/min 
compared with aortic blood flow (2.7 ± 0.2 mL/min). 
Average blood flow in the femoral artery was 0.86 ± 
0.1 mL/min, whereas average blood flow in the femoral vein 
was 0.19 ± 0.02 mL/min. The blood flow was significantly 
lower in the femoral artery and femoral vein than in the 
carotid artery (Figure 1B).
Vascular structure and function
The width of the blood vessel wall was measured by a digital 
micrometer. Aortic medial thickness was 1.6 µm ± 0.1, Vascular Health and Risk Management 2010:6 219
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carotid artery thickness was 0.95 µm ± 0.15, and femoral 
artery thickness was 0.6 µm ± 0.03 (Figures 2A and B). 
Blood flow and medial thickness of blood vessels showed a 
flow-structure relationship. Blood vessels with high blood 
flow consistently showed a higher medial thickness in com-
parison with blood vessels with low blood flow. Interestingly, 
the results suggested that a large change in blood flow from 
femoral artery to carotid artery caused a small increase in 
medial thickness; however, a small increase in blood flow 
from carotid artery to aorta caused significantly higher medial 
thickness (Figure 2C), suggesting a threshold relationship in 
blood flow and medial thickness.
Elastin:collagen ratio
Because elastin and collagen are the primary determinants 
of vascular medial thickness, we measured the elastin and 
collagen ratio. Trichrome blue staining of the arteries and 
veins revealed expression of collagen in the vein  femoral 
artery  carotid artery  aorta (Figure 3A). Conversely, 
van Gieson staining showed higher levels of elastin in the 
aorta and carotid artery than in the femoral artery and in the 
vena cava, as shown by the blackish-brown color staining 
(Figure 3A). Interestingly, the femoral artery showed an 
irregular and broken elastin structure (Figure 3A, arrow). 
The elastin:collagen ratio in the aorta was 1.18 ± .02; in 
the carotid artery the ratio was 1.03 ± 0.4, whereas in the 
femoral artery and vena cava it was 0.61 ± 0.1 and 0.57 ± 
0.1, respectively (Figure 3B). Blood vessels with high 
blood flow always showed a higher elastin:collagen ratio 
in comparison with blood vessels with low blood flow. 
Interestingly, the results suggested that a large change in 
blood flow from the femoral vein, artery to carotid artery 
caused a small increase in the elastin:collagen ratio. How-
ever, a small increase in blood flow from carotid artery to 
aorta caused a significantly higher elastin:collagen ratio 
(Figure 3C), suggesting a threshold relationship in blood 
flow and elastin:collagen ratio (a hallmark of vascular 
structural remodeling).
MMPs
Because vascular remodeling implies changes in vascular 
structure (ie, elastin:collagen ratio) and MMP specifically 
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regulates vascular remodeling, we measured MMP levels. 
MMP-9 had a significantly higher expression in the femoral 
artery (P = 0.01). Interestingly, this was correlated with 
elastin fragments in the femoral artery (Figure 3A, arrow). 
MMP-12 had the same level of expression in all blood 
vessels without any significant change in expression. 
MMP-13 also did not show any differential expression 
in the blood vessels (P = 0.07 and P = 0.14 indicated no 
statistically significant difference between the groups in 
MMP-12 and MMP-13, respectively, n = 4). MMP-2 showed 
high expression in the aorta, whereas it showed a low expres-
sion in the carotid and femoral arteries (Figure 4A and C) 
which was similar to the results found by zymography 
(Figure 4B). As revealed from the zymography study, 
MMP-2 activity was more pronounced in aorta tissue and 
in the carotid artery, in both pro- (upper band) and active 
(lower band) forms, whereas MMP-2 activity in both forms 
was found to have a low level of expression in the femoral 
arterial and vena cava tissues.
TIMPs
TIMP-3 was found to be significantly high in the femoral 
artery, while in the carotid artery and vein the protein was 
found to have significantly lower expression (P = 0.03, 
  Figures 5A and B). TIMP-4 expressions in the carotid artery 
showed significantly lower expression compared with other 
vessels (P = 0.03). Protein bands showed both glycosylated 
(higher molecular weight protein band) and nonglycosylated 
(lower molecular weight protein band) forms of TIMP-3 
and TIMP-4 (Figures 5A and 5B).
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Relationship between blood  
flow and MMP:TIMP ratio
Because the MMP:TIMP ratio dictates vascular structural 
(elastin:collagen) remodeling, we investigated the relationship 
between blood flow and total MMP:TIMP ratio. Vessels with 
high blood flow showed a higher MMP-2 expression in 
comparison with vessels with low blood flow and vice versa. 
The correlation between blood flow and elastin:collagen ratio 
or medial thickness was reversed in relation to total MMP:
TIMP ratio. Vessels with high blood flow always showed 
a lower total MMP:TIMP ratio in comparison with vessels 
with low blood flow. Interestingly, the results suggested that 
a small change in blood flow from femoral vein to femoral 
artery caused a large decrease in the total MMP:TIMP ratio; 
however, a further increase in blood flow from carotid artery 
to aorta did not significantly change the total MMP:TIMP 
ratio (Figure 5C), suggesting a threshold relationship in blood 
flow and total MMP:TIMP ratio. A small change in flow 
caused a large change in total MMP:TIMP ratio (a regulator 
of remodeling).
Vascular structure and function  
relationship
The vascular passive length-tension relationship was 
measured by stretching the vessels and measuring the tension 
generated. The results revealed that veins developed higher 
tension to stretch than did arteries (Figure 6). Interestingly, 
veins had lower levels of elastin but higher levels of collagen 
than did arteries. These results demonstrated unequivocally 
that the higher the elastin content in the tissue, the higher the 
compliance in that tissue.
Discussion
We tested whether the gradient of blood flow in different 
arteries and veins caused structural and functional 
heterogeneity as demonstrated by the structure of the blood 
vessels. The comparative medial thickness of the aorta, 
carotid artery, and femoral artery showed that the aorta had 
the highest medial thickness, whereas the femoral artery 
had the lowest medial thickness in the experimental group. 
Blood flow was highest in the aorta and lowest in the femoral 
artery and femoral vein, which indicated a proportional 
relationship between blood flow and medial thickness of the 
vessel wall. An increase in blood flow was observed with an 
increase in medial thickness of blood vessels.
The elastin:collagen ratio, measured by expression of 
elastin and collagen in the aorta, carotid artery, and femoral 
artery and vein showed a high ratio in the carotid artery 
and aorta, whereas the ratio was significantly lower in the 
femoral artery and vein. Also, the blood flow and elastin:
collagen ratio shows a reciprocal relationship. A small 
increase in blood flow from vein to femoral artery causes a 
small increase in the elastin:collagen ratio, whereas in a high 
blood flow vessel like the carotid artery and aorta, a small 
change in blood flow can cause a significant increase in the 
elastin:collagen ratio. These results indicate that arteries 
near to the heart have a high blood flow and more elastin 
compliance. Therefore, the ratio of elastin and collagen tend 
to decrease with increasing distance from the heart. This 
result is in accordance with previously reported findings.4–6 
It is possible that these arteries have adapted to high pulsatile 
blood pressure by increasing their medial thickness and the 
elastin level in the arteries, which ultimately gives the artery 
a high level of compliance and stability.
MMP-2 expression was significantly higher in the aorta 
in comparison with the other arteries and veins in our study, 
in both active and pro- forms. This findings are in accor-
dance with those of Watts et al26 because MMP-2 degrades 
collagen 1, 2, and 3, this may be a possible cause of the 
significantly higher elastin:collagen ratio in the aorta in 
comparison with the veins. This may contribute towards the 
low susceptibility of the aorta to developing atherosclerosis in 
comparison with the femoral artery.35 MMP-9 was expressed 
in high levels in the femoral artery, in comparison with the 
other arteries and veins of interest. Previous reports showed 
that MMP-9 degrades elastin37 which can be a leading cause 
of the femoral artery having a low elastin:collagen ratio. 
The high MMP-9 expression and the low elastin:collagen 
ratio may contribute towards the femoral artery being highly 
prone to atherosclerosis.35 Also, the breakdown of elastin 
by MMP-9 may cause discontinuous elastin structure in the 
femoral artery (Figure 3A, arrow).
TIMP-3 expression was significantly higher in the 
femoral artery in comparison with the carotid artery. TIMP-
4 was expressed at high levels in the aorta and in the vena 
cava, and this protein is known to inhibit MMP-9.9 High 
expression of TIMP-4 in the aorta and vena cava may con-
tribute to the low level of expression of MMP-9 in these 
tissues, as found in our study. High expression of TIMP-4 
may contribute to lower MMP-9 expression in these ves-
sels, which ultimately results in upregulation of elastin and 
a high elastin:collagen ratio in the aorta. Although the vena 
cava also has a high level of TIMP-4 in comparison with 
the other vessels studied, the reason for the lower amount 
of elastin expression in the vena cava and the low elastin:Vascular Health and Risk Management 2010:6 225
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collagen ratio is not clearly understood. Other factors may 
play a role in the downregulation of elastin expression in 
the vena cava.
Blood flow, when compared with the total vascular 
MMP:TIMP ratio, showed that the vein had the least blood 
flow and highest total MMP:TIMP ratio of the studied 
blood vessels. With a small increase in blood flow, the 
total MMP:TIMP ratio falls dramatically in the femoral 
artery, but with a significant increase in blood flow in the 
carotid artery and aorta, in comparison with the vein and 
femoral artery, the total MMP/TIMP ratio does not change 
significantly.
In the passive stretch-tension relationship, the vena cava 
showed the maximum response to stretch, because this vessel 
has the minimum elastin content and maximum amount of 
collagen, whereas the aorta showed the minimum response to 
that, as this blood vessel has the maximum amount of elastin 
and minimum amount of collagen of the arteries studied. 
Figure 5 C) Relationship between MMP:TIMP ratio and the blood flow. In order to get the MMP:TIMP ratio, averaged scanned data of MMPs in each of the blood vessels was 
calculated and divided by the averaged scanned units of TIMPs from the blood vessel. MMP:TIMP ratio was plotted in the y axis and the blood flow was plotted in the x axis. 
The vena cava has the highest MMP:TIMP ratio and the lowest blood flow in comparison with the other blood vessels.
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This result is consistent with the notion that the greater the 
elastin content, the greater the vascular compliance.
Conclusion
Different vascular beds have differential susceptibility to 
developing disease, in particular atherosclerosis.38,39 The 
elastin:collagen ratio and the matrix metalloproteases play a 
crucial role in vascular remodeling and in the development of 
atherosclerosis. We hypothesized that the gradient of blood 
flow in different arteries and veins results in structural and 
functional heterogeneity that ultimately leads to vascular 
remodeling. Our results show that blood flow, along with 
the elastin:collagen ratio and medial vessel thickness, play a 
key role in triggering vascular remodeling. High blood flow 
and a high elastin:collagen ratio are inversely correlated 
with vascular remodeling. The total MMP:TIMP ratio is 
significant in maintaining normal blood vessel structure. The 
importance of our findings in terms of cardiovascular health 
are multifactorial in the sense that flow-mediated changes in 
vascular structure may dictate whether the vessel is prone to 
developing atheroma faster than other vessels. In addition, the 
physiologic and clinical importance of the elastin:collagen 
ratio and MMPs in vascular remodeling and the process of 
atherosclerosis can be pinpointed to the structure and matrix 
metabolomic level, and will have therapeutic ramifications 
for structural vascular disease.
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